Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

. 2013 May-Jun;29(3):758–761. doi: 10.12669/pjms.293.2622

Table-II.

Comparison between results of PUVA and PUVB therapy

PUVA
N=25
PUVB
N=25
Number of patients cleared 23(92%) 20(80%)
Number of treatments required for clearance 15 16
Average duration of treatment (weeks) 8 8
HHS Vulnerability Disclosure